Literature DB >> 8128422

[Pharmacokinetics of paracetamol in the cerebrospinal fluid in the elderly].

X Moreau1, L Le Quay, J C Granry, N Boishardy, A Delhumeau.   

Abstract

We investigated acetaminophen pharmacokinetics in CSF in twelve operated arteritics patients with continuous spinal anesthesia. Nine men and three women aged 77 +/- 7 years and weighing 66 +/- 15 kg entered in the study after expressing verbal informed consent. They received intravenously a single dose of acetominophen (equivalent to 1 g). Fifteen minutes to six hours after the intravenous injection, blood and CSF samples were withdrawn every thirty minutes, except during the second to the third hour were it was every fifteen minutes. Acetaminophen concentrations in blood and in CSF were assayed by HPLC. Acetaminophen was detected in the earliest samples (1.32 +/- 1.32 micrograms.ml-1) and then increased up to 8.16 +/- 3.04 micrograms.ml-1 at 186 +/- 56 minutes. From 135th to 345th minute, acetaminophen concentration in CSF stay at about 6 micrograms.ml-1, which is the duration of its maximal analgesic central effect.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8128422

Source DB:  PubMed          Journal:  Therapie        ISSN: 0040-5957            Impact factor:   2.070


  3 in total

1.  Population pharmacokinetic modelling of intravenous paracetamol in fit older people displays extensive unexplained variability.

Authors:  P Mian; M J van Esdonk; K T Olkkola; B C M de Winter; A Liukas; I Spriet; D Tibboel; M Petrovic; B C P Koch; K Allegaert
Journal:  Br J Clin Pharmacol       Date:  2018-10-25       Impact factor: 4.335

2.  Acetaminophen in cerebrospinal fluid in children.

Authors:  C D van der Marel; B J Anderson; M A L Pluim; T H R de Jong; A Gonzalez; D Tibboel
Journal:  Eur J Clin Pharmacol       Date:  2003-07-04       Impact factor: 2.953

Review 3.  Paracetamol in Older People: Towards Evidence-Based Dosing?

Authors:  Paola Mian; Karel Allegaert; Isabel Spriet; Dick Tibboel; Mirko Petrovic
Journal:  Drugs Aging       Date:  2018-07       Impact factor: 3.923

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.